mRNA |
pac-1 |
CTRPv2 |
pan-cancer |
AAC |
0.018 |
0.6 |
mRNA |
16-beta-bromoandrosterone |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.6 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.017 |
0.6 |
mRNA |
dexamethasone |
CTRPv2 |
pan-cancer |
AAC |
-0.016 |
0.6 |
mRNA |
BRD-K41334119 |
CTRPv2 |
pan-cancer |
AAC |
0.033 |
0.6 |
mRNA |
968 |
CTRPv2 |
pan-cancer |
AAC |
-0.031 |
0.6 |
mRNA |
SR1001 |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.6 |
mRNA |
tacedinaline |
CTRPv2 |
pan-cancer |
AAC |
0.018 |
0.7 |
mRNA |
GSK1059615 |
CTRPv2 |
pan-cancer |
AAC |
-0.022 |
0.7 |
mRNA |
Bosutinib |
CTRPv2 |
pan-cancer |
AAC |
0.016 |
0.7 |